JP Morgan Chase
VOR icon

JP Morgan Chase’s Vor Biopharma VOR Stock Holding History

JP Morgan Chase’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.2K Buy
4,364
+2,052
+89% +$28.9K ﹤0.01% 6074
2025
Q4 		$30.2K Buy
2,312
+2,234
+2,864% +$41.6K ﹤0.01% 6409
2025
Q3 		$3.8K Sell
78
-372
-83% -$15K ﹤0.01% 6814
2025
Q2 		$14.6K Buy
450
+357
+384% +$3.15K ﹤0.01% 6248
2025
Q1 		$1.33K Sell
93
-440
-83% -$10.6K ﹤0.01% 6594
2024
Q4 		$11.8K Sell
533
-69
-11% -$1.14K ﹤0.01% 6358
2024
Q3 		$8.43K Buy
602
+553
+1,129% +$10.1K ﹤0.01% 6399
2024
Q2 		$983 Sell
49
-760
-94% -$24.6K ﹤0.01% 6623
2024
Q1 		$38.4K Sell
809
-416
-34% -$18.3K ﹤0.01% 6031
2023
Q4 		$55.1K Sell
1,225
-40
-3% -$1.65K ﹤0.01% 5965
2023
Q3 		$53.7K Sell
1,265
-281
-18% -$15.2K ﹤0.01% 5781
2023
Q2 		$95.5K Sell
1,546
-4,851
-76% -$443K ﹤0.01% 5480
2023
Q1 		$689K Hold
6,397
– – ﹤0.01% 4297
2022
Q4 		$851K Sell
6,397
-57
-0.9% -$5.64K ﹤0.01% 4162
2022
Q3 		$514K Sell
6,454
-2,115
-25% -$208K ﹤0.01% 4448
2022
Q2 		$852K Sell
8,569
-590
-6% -$60.4K ﹤0.01% 4221
2022
Q1 		$1.11M Sell
9,159
-1,039
-10% -$177K ﹤0.01% 4189
2021
Q4 		$2.37M Sell
10,198
-1,193
-10% -$344K ﹤0.01% 3723
2021
Q3 		$3.57M Buy
11,391
+10,860
+2,045% +$3.23M ﹤0.01% 3320
2021
Q2 		$199K Sell
531
-1,083
-67% -$534K ﹤0.01% 5252
2021
Q1 		$1.39M Buy
+1,614
New +$1.37M ﹤0.01% 3977

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

JP Morgan Chase's VOR Position: Q1 2026 in Review

JP Morgan Chase increased its Vor Biopharma (VOR) stake by 89% in Q1 2026, buying an estimated $28.9K and bringing the position to 4,364 shares worth $64.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6074.

JP Morgan Chase first reported a position in VOR in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.57M in Q3 2021. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • JP Morgan Chase held 4,364 shares of Vor Biopharma worth $64.2K as of Q1 2026.
  • JP Morgan Chase bought 2,052 Vor Biopharma shares in Q1 2026, an estimated $28.9K.
  • Vor Biopharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6074 holding.
  • JP Morgan Chase first reported a position in Vor Biopharma in Q1 2021 and has held it in 21 quarters since.
  • JP Morgan Chase's Vor Biopharma position peaked at $3.57M in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.